SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 6,846,776
- Share change
- -333,491
- Total reported value
- $44,307,000
- Price per share
- $6.47
- Number of holders
- 5
- Value change
- -$2,179,000
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP P8696W104:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.8%
|
2,718,735
|
$340,500,000 | — | 30 Sep 2022 | |
| Vivo Capital, LLC |
13F
|
Company |
8.2%
|
5,900,000
|
$38,173,000 | — | 30 Sep 2022 | |
| Neumann Advisory Hong Kong Ltd |
13F
|
Company |
0.44%
|
315,586
|
$2,042,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.3%
|
2,375,841
|
$1,537,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
160,875
|
$1,041,000 | — | 30 Sep 2022 | |
| Yorktown Management & Research Co Inc |
13F
|
Company |
0.1%
|
74,893
|
$485,000 | — | 30 Sep 2022 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.06%
|
40,000
|
$259,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,717
|
$179,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
16,430
|
$106,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
13,787
|
$55,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
4,141
|
$27,000 | — | 30 Sep 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
412
|
$27,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,000
|
$19,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,095
|
$14,000 | — | 30 Sep 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,685
|
$11,000 | — | 30 Sep 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
18
|
$8,000 | — | 30 Sep 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0%
|
656
|
$1,000 | — | 30 Sep 2022 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
102
|
$1,000 | — | 30 Sep 2022 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q4 2022
As of 31 Dec 2022,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,846,776 shares.
The largest 5 holders included
Vivo Capital, LLC, Neumann Advisory Hong Kong Ltd, Neumann Advisory Hong Kong Ltd, Neumann Advisory Hong Kong Ltd, and IFP Advisors, Inc.
This page lists
5
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
15
Q4 2022 holders
5
Holder diff
-10
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.